| Financial Year |
September 30 2022 |
| Monetary Funds |
828,322,428.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
273,550,462.40 |
| Accounts Receivable |
4,178,006,404.10 |
| Advances to Suppliers |
1,309,467,048.98 |
| Other Receivables |
3,585,808,711.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,143,340,468.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,276,607.86 |
| Total Current Assets |
22,290,074,898.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
284,547,456.00 |
| Investment Properties |
-- |
| Fixed Assetes |
1,186,832,660.53 |
| Under-construction Projects |
1,901,857,553.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
183,803,639.82 |
| R&D expenses |
17,258,219.78 |
| Goodwill |
1,762,333,024.13 |
| Long-Term Deferred and Prepaid Expenses |
5,130,304.75 |
| Deferred Income Tax Assets |
917,233,287.00 |
| Other Non-Current Assets |
68,663,378.28 |
| Sub-Total of Non-Current Assets |
6,348,196,372.23 |
| Total Assets |
28,638,271,270.59 |
| Short-Term Loans |
8,122,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
425,331,101.98 |
| Accounts Payable |
9,134,081,784.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
61,917,667.01 |
| Taxes Payable |
92,627,722.03 |
| Interest Payable |
241,008,431.72 |
| Dividend Payable |
-- |
| Other payables |
395,389,744.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,040,829,052.81 |
| Other Current Liabilities |
413,049,226.79 |
| Sub-Total of Current Liabilities |
23,524,164,589.96 |
| Long-term Loans |
3,064,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
17,176,332.15 |
| Sub-Total of Non-Current Liabilities |
3,101,264,860.25 |
| Total Liabilities |
26,625,429,450.21 |
| Paid-In Capital(Or Share Stock) |
858,904,477.00 |
| Capital Surplus |
2,195,859,294.71 |
| Surplus Reserve |
76,966,629.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,524,722,551.53 |
| Minority Stockholder's Interest |
400,808,589.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,612,033,230.60 |
| Owner's Equity（Stockholder's Equity） |
2,012,841,820.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,638,271,270.59 |
